Zurich Cantonal Bank Portfolio holdings
AUM
$40.9B
This Quarter Return
+3.36%
1 Year Return
+22.88%
3 Year Return
+106.76%
5 Year Return
+189.8%
10 Year Return
+428.78%
AUM
$35.1B
AUM Growth
+$35.1B
(+4.4%)
Cap. Flow
+$1.42B
Cap. Flow
% of AUM
4.06%
Top 10 Holdings %
Top 10 Hldgs %
34.43%
Holding
2,723
New
61
Increased
1,575
Reduced
466
Closed
67
Top Buys
| 1 |
Tesla
TSLA
|
$102M |
| 2 |
JPMorgan Chase
JPM
|
$93.8M |
| 3 |
Cisco
CSCO
|
$92.1M |
| 4 |
CME Group
CME
|
$89.3M |
| 5 |
Apple
AAPL
|
$81.1M |
Top Sells
| 1 |
UBS Group
UBS
|
$183M |
| 2 |
Applied Materials
AMAT
|
$70.5M |
| 3 |
Elevance Health
ELV
|
$66.4M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$60.6M |
| 5 |
D.R. Horton
DHI
|
$41.9M |
Sector Composition
| 1 | Technology | 30.45% |
| 2 | Financials | 16.86% |
| 3 | Healthcare | 11.59% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2551
American Public Education
APEI
$567M
| $7.31K | ﹤0.01% |
339
| – | – |
|
2552
Immunocore
IMCR
$1.78B
| $5.93K | ﹤0.01% |
201
-43
| -18% | -$1.27K |
|
2553
MacroGenics
MGNX
$121M
| $5.55K | ﹤0.01% |
1,707
| – | – |
|
|
AUTL
2554
Autolus Therapeutics
AUTL
$383M
| $4.89K | ﹤0.01% |
2,079
-485
| -19% | -$1.14K |
|
2555
Scilex Holding
SCLX
$131M
| $3.93K | ﹤0.01% |
263
-23
| -8% | -$344 |
|
2556
Wallbox
WBX
$65.7M
| $3.89K | ﹤0.01% |
466
| – | – |
|
2557
GoPro
GPRO
$234M
| $2.32K | ﹤0.01% |
2,127
| – | – |
|
2558
Inhibrx
INBX
$403M
| $1.82K | ﹤0.01% |
118
| – | – |
|
2559
Takeda Pharmaceutical
TAK
$47.8B
| $1.32K | ﹤0.01% |
+100
| New | +$1.32K |
|
|
ALLK
2560
DELISTED
Allakos
ALLK
| $1.17K | ﹤0.01% |
967
-7,944
| -89% | -$9.61K |
|
2561
Personalis
PSNL
$430M
| $1.17K | ﹤0.01% |
202
-3,004
| -94% | -$17.4K |
|
2562
Birkenstock
BIRK
$9.13B
| $850 | ﹤0.01% |
15
| – | – |
|
2563
GSK
GSK
$79.3B
| $812 | ﹤0.01% |
24
| – | – |
|
2564
BioXcel Therapeutics
BTAI
$52.7M
| $618 | ﹤0.01% |
103
-274
| -73% | -$1.64K |
|
2565
Talkspace
TALK
$444M
| $593 | ﹤0.01% |
192
| – | – |
|
2566
Pluri
PLUR
$40.5M
| $571 | ﹤0.01% |
136
-1,523
| -92% | -$6.39K |
|
2567
908 Devices
MASS
$214M
| $568 | ﹤0.01% |
258
-2,087
| -89% | -$4.6K |
|
2568
Sangamo Therapeutics
SGMO
$161M
| $445 | ﹤0.01% |
436
-5,680
| -93% | -$5.8K |
|
2569
ALX Oncology
ALXO
$54.6M
| $396 | ﹤0.01% |
237
-1,007
| -81% | -$1.68K |
|
|
ITRG
2570
Integra Resources
ITRG
$407M
| $356 | ﹤0.01% |
+413
| New | +$356 |
|
2571
Cabaletta Bio
CABA
$144M
| $343 | ﹤0.01% |
151
-647
| -81% | -$1.47K |
|
2572
Haleon
HLN
$44.3B
| $286 | ﹤0.01% |
30
| – | – |
|
2573
Precision BioSciences
DTIL
$59.5M
| $263 | ﹤0.01% |
69
-189
| -73% | -$720 |
|
2574
LivePerson
LPSN
$86M
| $243 | ﹤0.01% |
160
-484
| -75% | -$735 |
|
2575
RAPT Therapeutics
RAPT
$187M
| $198 | ﹤0.01% |
16
-73
| -82% | -$903 |
|